Literature DB >> 35099720

Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects.

Roberto Federico Villa1, Antonella Gorini2, Federica Ferrari2.   

Abstract

Clonidine is an anti-hypertensive drug that inhibits the release of norepinephrine from pre-synaptic terminals binding to pre-synaptic α2-adrenoreceptors. Some studies suggest that this drug decreases brain energy expenditure, particularly in hypoxic-ischemic injury. However, data about clonidine effects on the functional parameters regulating brain energy metabolism are lacking. In this study, the effects of acute clonidine treatment (5 μg×kg-1 i.p., 30 min) were evaluated on the catalytic activity of regulatory energy-linked enzymes of Krebs' cycle, Electron Transport Chain and glutamate metabolism of temporal cerebral cortex of 3-month-old male Sprague-Dawley rats. Enzyme activities were assayed on non-synaptic "free" mitochondria (FM) of neuronal perikaryon and partly of glial cells, and on intra-synaptic "light" (LM) and "heavy" mitochondria (HM), localized within synaptic terminals. This subcellular analysis differentiates clonidine effects on post-synaptic and pre-synaptic neuronal compartments. The results showed that clonidine increased citrate synthase, cytochrome oxidase and glutamate-oxaloacetate transaminase activities of FM. In LM, citrate synthase activity was decreased, while cytochrome oxidase and glutamate-oxaloacetate transaminase activities were increased; on the contrary, citrate synthase, cytochrome oxidase and glutamate dehydrogenase were all decreased in HM. Therefore, clonidine exerted different effects with respect to brain mitochondria, coherently with the in vivo energy requirements of each synaptic compartment: the drug increased energy-linked enzyme activities in post-synaptic compartment, while the metabolic variations were complex in the pre-synaptic one, being enzyme activities heterogeneously modified in LM and decreased in HM. This study highlights the relationships existing between the clonidine-induced neuroreceptorial effects and the energy metabolism in pre- and post- synaptic bioenergetics.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain energy metabolism; Clonidine; Enzymes; Glutamate; Mitochondria; Neuroprotection

Mesh:

Substances:

Year:  2022        PMID: 35099720     DOI: 10.1007/s11064-022-03541-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  87 in total

1.  An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina.

Authors:  H M Chao; G Chidlow; J Melena; J P Wood; N N Osborne
Journal:  Brain Res       Date:  2000-09-15       Impact factor: 3.252

2.  Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism.

Authors:  J S Schneider; J P Tinker; E Decamp
Journal:  Behav Brain Res       Date:  2010-03-27       Impact factor: 3.332

3.  The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.

Authors:  Mark E Bardgett; Megan Points; Christian Ramsey-Faulkner; Jeff Topmiller; John Roflow; Travis McDaniel; Timberly Lamontagne; Molly S Griffith
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

4.  Transport of clonidine across cultured brain microvessel endothelial cells.

Authors:  J Huwyler; G Fricker; M Török; M Schneider; J Drewe
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

5.  Oral clonidine pre-treatment and diazepam/meperidine sedation.

Authors:  D L Hall; D N Tatakis; J D Walters; E Rezvan
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

6.  The effect of clonidine on cell survival, glutamate, and aspartate release in normo- and hyperglycemic rats after near complete forebrain ischemia.

Authors:  W Scott Jellish; John Murdoch; Gisela Kindel; Xin Zhang; Fletcher A White
Journal:  Exp Brain Res       Date:  2005-07-26       Impact factor: 1.972

7.  Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.

Authors:  Surbhi Gupta; Bhupesh Sharma
Journal:  Eur J Pharmacol       Date:  2013-12-12       Impact factor: 4.432

8.  Changes in HPA reactivity and noradrenergic functions regulate spatial memory impairments at delayed time intervals following cerebral ischemia.

Authors:  Marc R Milot; Hélène Plamondon
Journal:  Horm Behav       Date:  2011-03-03       Impact factor: 3.587

9.  Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.

Authors:  Xu Wang; Guichu Li; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2005-05-09       Impact factor: 4.432

10.  Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat.

Authors:  Y Zhang
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.